Options
Etoricoxib and Diclofenac Might Reduce the Risk of Dementia in Patients with Osteoarthritis: A Nation-Wide, Population-Based Retrospective Cohort Study
Journal
Dementia and Geriatric Cognitive Disorders
Journal Volume
45
Journal Issue
5-6
Start Page
262-271
ISSN
1420-8008
1421-9824
Date Issued
2018
Author(s)
Yu-Hao Xue
Yu-Shin Peng
Hsin-Fu Ting
Jason Peijer Hsieh
Yu-Kai Huang
Yu-Hsun Wang
Abstract
<jats:p><b><i>Introduction:</i></b> This population-based cohort study investigates the association between osteoarthritis (OA) and dementia as well as the connection between NSAIDs and dementia. <b><i>Methods:</i></b> We chose the samples from the Taiwan Longitudinal Health Insurance Database and then divided them into two groups, which were then matched 1: 1 by propensity score. The first group was the OA group that contained patients with newly diagnosed OA and the second group was the non-OA group. We used the χ<sup>2</sup> test, Student <i>t</i> test, Kaplan-Meier analysis, and Cox proportional hazard model for different purposes. <b><i>Results:</i></b> The prevalence of dementia in the OA group was higher than that in the non-OA group. The adjusted hazard ratio of the former was 1.42 (95% CI, 1.30–1.54). We also found that etoricoxib and diclofenac might reduce the incidence of dementia. <b><i>Conclusion:</i></b> Patients with OA might have a higher risk of dementia. Both etoricoxib and diclofenac might lower the risk of dementia in patients with OA.</jats:p>
SDGs
Publisher
S. Karger AG
Type
journal-article